Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This Phase 1 study will assess the effects of esreboxetine on the heart. In particular the
effects on a specific electrocardiogram (ECG) measurement called QTc will be measured.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination